Cargando…

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data

BACKGROUND: The prevalence of HIV-1 resistance to antiretroviral therapies (ART) has declined in high-income countries over recent years, but drug resistance remains a substantial concern in many low and middle-income countries. The Q151M and T69 insertion (T69i) resistance mutations in the viral re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stirrup, Oliver T., Dunn, David T., Tostevin, Anna, Sabin, Caroline A., Pozniak, Anton, Asboe, David, Cox, Alison, Orkin, Chloe, Martin, Fabiola, Cane, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902836/ https://www.ncbi.nlm.nih.gov/pubmed/29661246 http://dx.doi.org/10.1186/s12981-018-0198-7

Ejemplares similares

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation
por: Stirrup, OT, et al.
Publicado: (2020)

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK
por: El Bouzidi, Kate, et al.
Publicado: (2016)

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance
por: Geretti, Anna Maria, et al.
Publicado: (2019)

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV
por: Stirrup, Oliver T, et al.
Publicado: (2019)

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction
por: Mbisa, Jean L, et al.
Publicado: (2019)

First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines
por: El Bouzidi, Kate, et al.
Publicado: (2020)

The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains
por: Mbisa, Jean L, et al.
Publicado: (2011)

Sonatine Op.151 e 168 : per pianoforte
por: Diabelli, Anton, 1781-1858
Publicado: (1991)

Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK
por: El Bouzidi, Kate, et al.
Publicado: (2014)

Scheduling of S69 ( $\Delta S/ \Delta Q$ rule ) after the shutdown
por: CERN. Geneva, et al.
Publicado: (1968)

Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151)
por: Davies, G, et al.
Publicado: (2016)

Outcomes of two different unbalanced segregations from a maternal t(4;10)(q33;p15.1) translocation
por: Fan, Judith, et al.
Publicado: (2023)

IAU Colloqium No. 151
por: Greiner, Jochen, et al.
Publicado: (1995)

S151. Submission Withdrawn
Publicado: (2018)

Contents of Volume 151
Publicado: (2014)

Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates
por: Stirrup, Oliver T., et al.
Publicado: (2018)

Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control
por: Volz, Erik M, et al.
Publicado: (2018)

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
por: May, Margaret, et al.
Publicado: (2011)

Sex-specific moderation by lifestyle and psychosocial factors on the genetic contributions to adiposity in 112,151 individuals from UK Biobank
por: Calvin, Catherine M., et al.
Publicado: (2019)

Proton radioactivity of $^{151}$Lu
por: Hofmann, S, et al.
Publicado: (1981)

151st LHCC Meeting
Publicado: (2022)

151st SPSC Meeting
Publicado: (2023)

Subject index for volume 151
Publicado: (1986)

CD151 in Respiratory Diseases
por: Wong, Amanda H., et al.
Publicado: (2020)

Health Tract, No. 151: Cholera
Publicado: (1863)

Health Tract, No. 151: Cholera
Publicado: (1864)

Health Tract, No. 151: Cholera
Publicado: (1865)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rate
por: Dunn, David T., et al.
Publicado: (2021)

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom
por: White, Ellen, et al.
Publicado: (2016)

D151. The Gender-Q: A Rigorous, Modular, Patient-reported Outcome Measure For Gender-affirming Care
por: Kaur, Manraj, et al.
Publicado: (2023)

Historical dynamics of the Chinese dynasties
por: Roman, Sabin
Publicado: (2021)

Dionysus in 69 /
Publicado: (1970)

Approved SPS Experiments-78-151
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1978)

Minutes of the 151st Meeting of the LHCC
por: CERN. Geneva. Large Hadron Collider Experiments Committee, et al.
Publicado: (2022)

The Tetraspanin CD151 in Papillomavirus Infection
por: Scheffer, Konstanze D., et al.
Publicado: (2014)

Nonsense Mutation in Coiled-Coil Domain Containing 151 Gene (CCDC151) Causes Primary Ciliary Dyskinesia
por: Alsaadi, Muslim M, et al.
Publicado: (2014)

K70Q Adds High-Level Tenofovir Resistance to “Q151M Complex” HIV Reverse Transcriptase through the Enhanced Discrimination Mechanism
por: Hachiya, Atsuko, et al.
Publicado: (2011)

Profiling of the Tetraspanin CD151 Web and Conspiracy of CD151/Integrin β1 Complex in the Progression of Hepatocellular Carcinoma
por: Devbhandari, Ranjan Prasad, et al.
Publicado: (2011)

151 quick ideas for delegating and decision making
por: Dittmer, Robert E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_nu857g4i42olgt84lr3mvgotft